pocketful logo
Vimta Labs Ltd logo

Vimta Labs Ltd

NSE: VIMTALABS BSE: 524394

380.70

(-5.15%)

Thu, 02 Apr 2026, 01:12 am

Vimta Labs Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

  • Market Cap

    1817.15

  • Net Profit

    41.01

  • P/B

    3.08

  • Sector P/E

    52.79

  • P/E

    24.03

  • EV/EBITDA

    10.78

  • Debt/Equity (Industry)

    0.57

  • Interest Cover (Industry)

    3.73

  • ROCE (Industry)

    6.03

  • RONW (Industry)

    5.29

  • ROE

    13.64

  • ROCE

    16.99

  • Debt/Equity

    0.06

  • EPS (TTM)

    13.61

  • Dividend Yield

    0.24

  • Book Value

    76.74

  • Interest Cover

    26.70

Analysis

all

thumbs up icon

Pros

  • Dividends per share have increased over the past 10 years.
  • Dividends paid are covered by earnings (1.6x coverage).
  • Vimta Labs's pays a higher dividend yield than the bottom 25% of dividend payers in India (0.76%).
  • Vimta Labs is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Vimta Labs is profitable, therefore cash runway is not a concern.
thumbs up icon

Cons

  • Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
  • Vimta Labs's dividend is below the markets top 25% of dividend payers in India (3.08%).
  • The level of debt compared to net worth has increased over the past 5 years (2.9% vs 13.4% today).
  • High level of physical assets or inventory.
  • The average tenure for the Vimta Labs board of directors is less than 3 years, this suggests a new board.

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersDEC 2025SEPT 2025JUN 2025MAR 2025DEC 2024
Promoters35.9035.9936.6736.7036.76
FII4.594.333.493.663.81
DII0.110.871.421.431.16
Public59.4158.8058.4258.2058.27
Government00000

Read More

Technical Analysis

RSI

43.36

MACD

-16.99

50 DMA

451.91

200 DMA

583.48

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic573.48489.53435.12405.58351.17321.63237.68
Fibonacci489.53457.46437.65405.58373.51353.70321.63
Camarilla403.79396.09388.40405.58373.00365.31357.61

Pivots Level: Classic

R3

+167.90

573.48

R2

+83.95

489.53

R1

+29.53

435.12

405.58
405.58
Pivot Point
LTP: 408.20

S1

-54.42

351.17

S2

-83.95

321.63

S3

-167.90

237.68

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    411.15

  • 20-EMA

    423.45

  • 30-EMA

    435.69

  • 50-EMA

    461.23

  • 100-EMA

    509.75

  • 200-EMA

    533.27

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
28 Jan 2026board-meetingsQuarterly Results
03 Nov 2025board-meetingsQuarterly Results
09 Jun 2025bonus1:1 Bonus Issue of Equity Shares13 Jun 2025
15 May 2025agm
13 May 2025bonusBonus issue 1:113 Jun 2025
30 Apr 2025dividendDividend - Rs. - 230 May 2025
28 Apr 2025dividend₹2.00 Dividend /Share30 May 2025
11 Jun 2024dividendAnnual General Meeting/Dividend - Rs 2 Per Share12 Jul 2024
18 May 2024agm
18 May 2024dividend₹2.00 Dividend /Share12 Jul 2024

Read More

Peer Comparison

Vimta Labs Ltd logo

Vimta Labs Ltd

Max Healthcare Institute Ltd logo

Max Healthcare Institute Ltd

Narayana Hrudayalaya Ltd logo

Narayana Hrudayalaya Ltd

Aster DM Healthcare Ltd logo

Aster DM Healthcare Ltd

Apollo Hospitals Enterprise Ltd logo

Apollo Hospitals Enterprise Ltd

Fortis Healthcare Ltd logo

Fortis Healthcare Ltd

Read More

Vimta Labs Ltd About

Vimta Labs provides multi-disciplinary contract research and testing services in India in the areas of clinical research, pre-clinical (animal) studies, clinical reference lab services, environmental assessments and analytical testing of a wide variety of products.

Industry

Miscellaneous

Founded

1990

Headquarters

CEO

S P Vasireddi

Employees

Contact

Website icon

Website

http://www.vimta.com

Email icon

Email

shares@vimta.com

Phone icon

Phone

91-40-27264141

Location icon

Location

Plot No 141/2 & 142, IDA Phase II Cherlapally, Hyderabad, Telangana, 500051

Read More

Vimta Labs Ltd Company History

YearHistory
2011
  • The Board recommended a dividend of Rs. 0.40/- per equity share of Rs. 2/- each.
2013
  • The Board recommended a dividend of 0.60 paise per face value of Rs. 2/- each share.
2014
  • The Board recommended a dividend of Rs. 2 per face value of Rs. 2/- each share.
2020
  • Vimta Labs completed the acquisition of shares of M/s Emtac Laboratories Private Limited.
2024
  • Vimta Labs Limited amalgamated with its wholly owned subsidiary Emtac Laboratories Private Limited.

Read More

Deals

Client NameOrder SideQTYAvg PriceDate
HRTI PRIVATE LIMITEDBuy295059753.5725 Sept 2025
HRTI PRIVATE LIMITEDSell294330755.6825 Sept 2025
GRAVITON RESEARCH CAPITAL LLPSell248631821.919 Sept 2025
GRAVITON RESEARCH CAPITAL LLPBuy248631821.3219 Sept 2025
SPDR PORTFOLIO EMERGING MARKETS ETFBuy346373824.0519 Sept 2025
HRTI PRIVATE LIMITEDBuy376745821.3119 Sept 2025
HRTI PRIVATE LIMITEDSell393620822.8119 Sept 2025
HRTI PRIVATE LIMITEDSell252556806.1811 Sept 2025
HRTI PRIVATE LIMITEDBuy260682799.6211 Sept 2025
HRTI PRIVATE LIMITEDBuy230421826.4409 Sept 2025

Read More

Vimta Labs Ltd News

Vimta Labs reschedules analyst meets to March 31

Vimta Labs Limited has rescheduled its analyst meeting with Valcore Capital to March 31, 2026, and added a new meeting with CVC Partners on the same day under SEBI compliance.

28 Mar 2026

companies

Vimta Labs reschedules analyst meet to March 31, 2026

Vimta Labs Limited has rescheduled its analyst meeting with Valcore Capital to March 31, 2026, and added a new meeting with CVC Partners on the same day under SEBI compliance.

28 Mar 2026

companies

Vimta Labs schedules investor meet with Valcore Capital

Vimta Labs Limited has scheduled an analyst/institutional investor meeting with Valcore Capital on March 27, 2026, to be conducted online at 3:00 PM IST under SEBI Regulation 30 compliance.

24 Mar 2026

companies

Vimta Labs Allots 34,166 ESOPs Under 2021 Plan

Vimta Labs Limited allotted 34,166 employee stock options under its ESOP Plan 2021, increasing paid-up share capital from ₹8,92,70,378 to ₹8,93,38,710 with shares ranking pari-passu.

09 Mar 2026

co actions results

VIMTA Labs Q3 Net Profit Rises to ₹176M

VIMTA Labs reported a net profit of ₹176 million for Q3, marking a marginal increase from ₹175 million in the corresponding quarter of the previous year, representing steady performance.

28 Jan 2026

co actions results

Read More

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

pocketful logo

2022-25 Pocketful. All rights reserved, Built with in India

Version -5.76

app image 1app image 2

Explore

Calculatorsfooter arrow down icon
Popular Calculatorsfooter arrow down icon
Group Stocksfooter arrow down icon

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800